Search Results Search Sort by RelevanceMost Recent Viewpoint Jul 2013 Educational Debt and Specialty Choice Albert L. Hsu, MD and Kelly Caverzagie, MD Virtual Mentor. 2013;15(7):615-619. doi: 10.1001/virtualmentor.2013.15.7.oped1-1307. Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.
Viewpoint Jul 2013 Educational Debt and Specialty Choice Albert L. Hsu, MD and Kelly Caverzagie, MD Virtual Mentor. 2013;15(7):615-619. doi: 10.1001/virtualmentor.2013.15.7.oped1-1307.
Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.